Last reviewed: June 30, 2026 Last updated: June 30, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Storage conditions must be kept optimum to keep it stable and sterile
This peptide blend is supplied exclusively for laboratory research, analytical testing, and in-vitro scientific investigation
C.2000N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review.1519(May 2000),846861,0002-9262 13
A single intratympanic injection of any one of the formulations described herein is administered 24 hours prior to start of cisplatin treatment